Mainstream

Bristol Myers To Report Q4 Iprd/licensing Expense Of $18m

Bristol Myers to report Q4 IPRD/licensing expense of $18M

Bristol Myers to report Q4 IPRD/licensing expense of $18M

Post ContentbmyRead More

You might also be interested in reading WLF investor Aqua1 offers few answers to alleged Web3Port ties.

January 6, 2025
In Mainstream